157 related articles for article (PubMed ID: 23993024)
1. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
[TBL] [Abstract][Full Text] [Related]
2. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck.
Chen AM; Daly ME; El-Sayed I; Garcia J; Lee NY; Bucci MK; Kaplan MJ
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):338-43. PubMed ID: 18207030
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
Su YR; Wu GH; Zeng ZY; Guo ZM; Chen WK; Wei MW; Chen YF
Ai Zheng; 2008 May; 27(5):535-8. PubMed ID: 18479606
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
8. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive endoscopic resection of sinonasal undifferentiated carcinoma.
Revenaugh PC; Seth R; Pavlovich JB; Knott PD; Batra PS
Am J Otolaryngol; 2011; 32(6):464-9. PubMed ID: 21041001
[TBL] [Abstract][Full Text] [Related]
10. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
11. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.
Zielinski V; Laban S; Tribius S; Schafhausen P; Veldhoen S; Knecht R; Clauditz T; Muenscher A
Ear Nose Throat J; 2016 Jan; 95(1):23-8. PubMed ID: 26829682
[TBL] [Abstract][Full Text] [Related]
12. Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.
Fried D; Zanation AM; Huang B; Hayes N; Morris DE; Rosenman J; Varia M; Funkhouser W; Weissler M; Chera BS
Laryngoscope; 2012 Oct; 122(10):2210-5. PubMed ID: 22886723
[TBL] [Abstract][Full Text] [Related]
13. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal undifferentiated carcinoma: the search for a better outcome.
Musy PY; Reibel JF; Levine PA
Laryngoscope; 2002 Aug; 112(8 Pt 1):1450-5. PubMed ID: 12172261
[TBL] [Abstract][Full Text] [Related]
15. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience.
Bhasker S; Mallick S; Benson R; Bhanuprasad V; Sharma A; Thakar A
J Laryngol Otol; 2017 Jan; 131(1):19-25. PubMed ID: 27938440
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
18. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
[TBL] [Abstract][Full Text] [Related]
19. Current management of sinonasal undifferentiated carcinoma.
Lopez F; Suárez V; Vivanco B; Suárez C; Llorente JL
Rhinology; 2015 Sep; 53(3):212-20. PubMed ID: 26363162
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for sinonasal undifferentiated carcinoma.
Christopherson K; Werning JW; Malyapa RS; Morris CG; Mendenhall WM
Am J Otolaryngol; 2014; 35(2):141-6. PubMed ID: 24268566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]